Financings

ChanRx Corp. raised $5.5 million in a Series A round for its atrial fibrillation drug.

Coronado Biosciences Inc.'s stock debuted on the Over The Counter Bulletin Board at $11 after taking a Form 10 path to get public.

Portola Pharmaceuticals Inc. raised $89 million in a Series D financing.

Deals

Excaliard Pharmaceuticals Inc. is being acquired by Pfizer Inc. (no terms).

Gilead Sciences Inc. announced plans to acquire Pharmasset Inc. for $11 billion.

. . . And More

EUSA Pharma Inc. got FDA approval of acute lymphoblastic leukemia drug Erwinaze.

Regeneron Pharmaceuticals Inc.'s Eylea (aflibercept) gained FDA approval for wet AMD.

Roche AG/Genentech Inc.'s FDA approval of Avastin (bevacizumab) for breast cancer was revoked.